Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedApr 18, 2026
DataAggregated Company Financials
Companies2
  • 7D10.1%
  • 3M-40.7%
  • 1Y-15.7%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 2.4%, with all of the companies up. In contrast, the industry has lost 20% in the last 12 months. As for the next few years, earnings are forecast to decline by 7.1% per annum.

Industry Valuation and Performance

Has the Danish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 18 Apr 2026DKK 11.9bDKK 3.1bDKK 1.9b18.9x6.4x3.8x
Mon, 16 Mar 2026DKK 13.0bDKK 3.1bDKK 1.9b21.4x6.9x4.1x
Wed, 11 Feb 2026DKK 13.9bDKK 3.1bDKK 1.9b22.2x7.2x4.4x
Fri, 09 Jan 2026DKK 21.0bDKK 3.1bDKK 1.9b35.9x10.9x6.7x
Sun, 07 Dec 2025DKK 20.8bDKK 3.1bDKK 1.9b36.9x10.8x6.6x
Tue, 04 Nov 2025DKK 20.7bDKK 3.1bDKK 1.9b38.9x10.7x6.6x
Thu, 02 Oct 2025DKK 18.1bDKK 3.1bDKK 1.9b32.2x9.4x5.8x
Sat, 30 Aug 2025DKK 15.2bDKK 3.1bDKK 1.9b28.6x7.9x4.9x
Mon, 28 Jul 2025DKK 15.6bDKK 725.3mDKK 132.6m53x118x21.6x
Wed, 25 Jun 2025DKK 17.7bDKK 725.3mDKK 132.6m54.8x133.2x24.4x
Fri, 23 May 2025DKK 15.3bDKK 725.3mDKK 132.6m52.7x115.4x21.1x
Sun, 20 Apr 2025DKK 14.1bDKK 725.3mDKK 132.6m49.3x106.7x19.5x
Tue, 18 Mar 2025DKK 18.0bDKK 725.3mDKK 132.6m55.6x135.6x24.8x
Thu, 13 Feb 2025DKK 20.9bDKK 683.4mDKK 122.6m58.8x170.5x30.6x
Sat, 11 Jan 2025DKK 20.4bDKK 631.7mDKK 89.8m70.1x227.4x32.3x
Mon, 09 Dec 2024DKK 19.8bDKK 631.7mDKK 89.8m61.5x220.6x31.3x
Wed, 06 Nov 2024DKK 13.6bDKK 631.7mDKK 89.8m49.5x151x21.5x
Fri, 04 Oct 2024DKK 14.6bDKK 631.7mDKK 89.8m50.7x162.4x23.1x
Sun, 01 Sep 2024DKK 15.8bDKK 625.4mDKK 97.3m45.3x162.2x25.2x
Tue, 30 Jul 2024DKK 16.8bDKK 606.5mDKK 99.3m44.8x169.2x27.7x
Thu, 27 Jun 2024DKK 12.6bDKK 606.5mDKK 99.3m37x127x20.8x
Sat, 25 May 2024DKK 11.4bDKK 606.5mDKK 99.3m44.4x115.3x18.9x
Mon, 22 Apr 2024DKK 9.6bDKK 606.5mDKK 99.3m34.5x96.4x15.8x
Wed, 20 Mar 2024DKK 12.5bDKK 606.5mDKK 99.3m51.1x125.7x20.6x
Fri, 16 Feb 2024DKK 10.2bDKK 605.1mDKK 136.8m53.5x74.8x16.9x
Sun, 14 Jan 2024DKK 8.6bDKK 647.9mDKK 171.7m36.9x50.1x13.3x
Tue, 12 Dec 2023DKK 7.9bDKK 647.9mDKK 171.7m33.2x45.9x12.2x
Thu, 09 Nov 2023DKK 7.9bDKK 647.9mDKK 171.7m34.1x46.2x12.2x
Sat, 07 Oct 2023DKK 7.4bDKK 647.9mDKK 171.7m32.2x43.4x11.5x
Mon, 04 Sep 2023DKK 9.3bDKK 664.8mDKK 172.7m41.4x53.9x14x
Wed, 02 Aug 2023DKK 9.2bDKK 660.6mDKK 184.0m198.8x49.9x13.9x
Fri, 30 Jun 2023DKK 9.4bDKK 660.6mDKK 184.0m200.1x51.1x14.2x
Sun, 28 May 2023DKK 9.9bDKK 660.6mDKK 184.0m216.6x53.7x15x
Tue, 25 Apr 2023DKK 6.3bDKK 461.2mDKK 179.7m34.8x34.8x13.6x
Price to Earnings Ratio

34.8x


Total Market Cap: DKK 6.3bTotal Earnings: DKK 179.7mTotal Revenue: DKK 461.2mTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Clinical Research and Equipment Industry Price to Earnings3Y Average 88.8x202420252026
Current Industry PE
    There are only 2 companies in the Danish Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 118% per year over the last three years.
  • Revenues for these companies have grown 89% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Danish Clinical Research and Equipment compare with similar industries?

DK Market2.96%
Healthcare7.16%
Life Sciences10.07%
Clinical Research and Equipment10.07%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CHEMM ChemoMetecDKK 350.0015.4%
+DKK 811.0m		-27.0%PE34.4x
GUBRA GubraDKK 358.005.0%
+DKK 280.9m		0.6%PE3.5x

Latest News

CHEMM
DKK 350.00
ChemoMetec
7D
15.4%
1Y
-27.0%
GUBRA
DKK 358.00
Gubra
7D
5.0%
1Y
0.6%

GUBRA: Obesity Study And Ventures Unit Will Drive Long Term Upside

Analysts have kept their DKK 469.5 price target on Gubra unchanged, citing only marginal adjustments to assumptions such as the discount rate and forward P/E as the basis for this maintained view. What's in the News Gubra submitted a clinical trial application in Germany for GUB-UCN2, a first in human Phase 1/2a study designed to assess safety, tolerability, pharmacokinetics and preliminary efficacy, including muscle volume and muscle function endpoints, in about 188 participants across multiple indications and patient groups (Key Developments).